Prevalence of antibodies against Tick-Borne Encephalitis Virus in blood donors in the states of Saxony and Berlin/Brandenburg, eastern Germany.

Authors

Philipp Girl, Anne B Schindler, Johannes P Borde, Michael Schmidt, Gerhard Dobler

Published in

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. Pages 109133. Sep 20, 2026. Epub Sep 20, 2026.

Abstract

Tick-borne encephalitis virus (TBEV) is a major vector-borne pathogen in Europe, but its true infection burden remains unclear due to the high proportion of asymptomatic infections and the inability of conventional serology to distinguish vaccination- from infection-induced antibodies. We applied a non-structural protein 1 (NS1)-based serological approach to estimate TBEV seroprevalence, incidence, and manifestation index in eastern Germany (Saxony and Berlin/Brandenburg).
A total of 1,391 anonymized blood donor sera (18-72 years), collected between May and September 2021, were analyzed using commercial TBEV IgG ELISA, an in-house NS1 IgG ELISA, and micro-neutralization testing.
Overall, 39.8% of samples were TBEV IgG-positive, indicating vaccination- and/or infection-induced immunity. NS1 antibodies, reflecting past or recent infection, were detected in 1.3% of donors. Estimated vaccination coverage was 38.5%, with higher coverage in Saxony than in Berlin-Brandenburg (45.4% vs. 32.0%). NS1-based analyses revealed a mean annual incidence of 64.7 cases per 100,000 inhabitants, approximately 294-fold higher than notification-based estimates, with a 1000-fold difference in Berlin/Brandenburg. The overall manifestation index was 0.34%, indicating that >99% of infections remain asymptomatic or undiagnosed. Despite higher reported incidence in Saxony, NS1-based estimates indicated substantial infection activity in Berlin/Brandenburg.
NS1-based serology revealed a markedly underestimated TBEV infection burden and may improve surveillance, identification of emerging risk areas, and targeted vaccination strategies.

PMID:
42764039
Bibliographic data and abstract were imported from PubMed on 21 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.